{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T18:51:13Z","timestamp":1740163873601,"version":"3.37.3"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,10,21]],"date-time":"2022-10-21T00:00:00Z","timestamp":1666310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,10,21]],"date-time":"2022-10-21T00:00:00Z","timestamp":1666310400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003977","name":"Israel Science Foundation","doi-asserted-by":"publisher","award":["1233\/18"],"award-info":[{"award-number":["1233\/18"]}],"id":[{"id":"10.13039\/501100003977","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Scarcity of effective treatments against sepsis is daunting, especially under the contemporary standpoints on antibiotics resistance, entailing the development of alternative treatment strategies. Here, we describe the design and antibiotic adjuvant properties of a new lipopeptide-like pentamer, decanoyl-bis.diaminobutyrate-aminododecanoyl-diaminobutyrate-amide (C<jats:sub>10<\/jats:sub>BBc<jats:sub>12<\/jats:sub>B), whose sub-maximal tolerated doses combinations with inefficient antibiotics demonstrated systemic efficacies in murine models of peritonitis-sepsis and urinary-tract infections. Attempts to shed light into the mechanism of action using membrane-active fluorescent probes, suggest outer-membrane interactions to dominate the pentamer\u2019s adjuvant properties, which were not associated with typical inner-membrane damages or with delayed bacterial growth. Yet, checkerboard titrations with low micromolar concentrations of C<jats:sub>10<\/jats:sub>BBc<jats:sub>12<\/jats:sub>B exhibited unprecedented capacities in potentiation of hydrophobic antibiotics towards Gram-negative ESKAPE pathogens, with an apparent low propensity for prompting resistance to the antibiotics. Assessment of the pentamer\u2019s potentiating activities upon efflux inhibition incites submission of a hitherto unreported, probable action mechanism implicating the pentamer\u2019s <jats:italic>de-facto<\/jats:italic> capacity to hijack bacterial efflux pumps for boosting its adjuvant activity through repetitive steps including outer-membrane adhesion, translocation and subsequent expulsion.<\/jats:p>","DOI":"10.1038\/s41598-022-21526-4","type":"journal-article","created":{"date-parts":[[2022,10,21]],"date-time":"2022-10-21T12:06:36Z","timestamp":1666353996000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["An efflux-susceptible antibiotic-adjuvant with systemic efficacy against mouse infections"],"prefix":"10.1038","volume":"12","author":[{"given":"Ohad","family":"Meir","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fadia","family":"Zaknoon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amram","family":"Mor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,10,21]]},"reference":[{"key":"21526_CR1","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1056\/NEJMra1208623","volume":"369","author":"DC Angus","year":"2013","unstructured":"Angus, D. C. & Van Der Poll, T. Severe sepsis and septic shock. N. Engl. J. Med. 369, 840\u2013851 (2013).","journal-title":"N. Engl. J. Med."},{"key":"21526_CR2","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/S1473-3099(15)70112-X","volume":"15","author":"J Cohen","year":"2015","unstructured":"Cohen, J. et al. Sepsis: a roadmap for future research. Lancet Infect. Dis. 15, 581\u2013614 (2015).","journal-title":"Lancet Infect. Dis."},{"key":"21526_CR3","unstructured":"WHO. Current evidence, identifying gaps and future directions: global report on the epidemiology and burden of sepsis (2020)."},{"key":"21526_CR4","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/S0140-6736(19)32989-7","volume":"395","author":"KE Rudd","year":"2020","unstructured":"Rudd, K. E. et al. Global, regional, and national sepsis incidence and mortality, 1990\u20132017: analysis for the Global Burden of Disease Study. Lancet 395, 200\u2013211 (2020).","journal-title":"Lancet"},{"key":"21526_CR5","doi-asserted-by":"publisher","first-page":"2362","DOI":"10.1001\/jama.2009.815","volume":"301","author":"D Annane","year":"2009","unstructured":"Annane, D. et al. Corticosteroids in the treatment of severe sepsis and septic shock in adults: a systematic review. JAMA - J. Am. Med. Assoc. 301, 2362\u20132375 (2009).","journal-title":"JAMA - J. Am. Med. Assoc."},{"key":"21526_CR6","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1038\/nri3552","volume":"13","author":"RS Hotchkiss","year":"2013","unstructured":"Hotchkiss, R. S., Monneret, G. & Payen, D. Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy. Nat. Rev. Immunol. 13, 862\u2013874 (2013).","journal-title":"Nat. Rev. Immunol."},{"key":"21526_CR7","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/nri.2017.36","volume":"17","author":"T van der Poll","year":"2017","unstructured":"van der Poll, T., van de Veerdonk, F. L., Scicluna, B. P. & Netea, M. G. The immunopathology of sepsis and potential therapeutic targets. Nat. Rev. Immunol. 17, 407\u2013420 (2017).","journal-title":"Nat. Rev. Immunol."},{"key":"21526_CR8","first-page":"1","volume":"2","author":"RS Hotchkiss","year":"2016","unstructured":"Hotchkiss, R. S. et al. Sepsis and septic shock. Nat. Rev. Dis. Prim. 2, 1\u201321 (2016).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"21526_CR9","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1007\/s00134-018-5085-0","volume":"44","author":"MM Levy","year":"2018","unstructured":"Levy, M. M., Evans, L. E. & Rhodes, A. The surviving sepsis campaign bundle: 2018 update. Intensive Care Med. 44, 925\u2013928 (2018).","journal-title":"Intensive Care Med."},{"key":"21526_CR10","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.1097\/CCM.0000000000001142","volume":"43","author":"SA Sterling","year":"2015","unstructured":"Sterling, S. A., Miller, R., Pryor, J., Puskarich, M. A. & Jones, A. E. The impact of timing of antibiotics on outcomes in severe sepsis and septic shock: a systematic review and meta-analysis HHS public access. Crit Care Med 43, 1907\u20131915 (2015).","journal-title":"Crit Care Med"},{"key":"21526_CR11","doi-asserted-by":"crossref","unstructured":"Hoffman, P. S. Antibacterial discovery: 21st century challenges. Antibiotics 9, (2020).","DOI":"10.3390\/antibiotics9050213"},{"key":"21526_CR12","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a025288","volume":"6","author":"MJ Trimble","year":"2016","unstructured":"Trimble, M. J., Mlyn\u00e1r\u010dik, P., Kol\u00e1\u0159, M. & Hancock, R. E. W. Polymyxin: alternative mechanisms of action and resistance. Cold Spring Harb. Perspect. Med. 6, a025288 (2016).","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"21526_CR13","doi-asserted-by":"publisher","first-page":"e216","DOI":"10.1016\/S1473-3099(20)30327-3","volume":"20","author":"M Magana","year":"2020","unstructured":"Magana, M. et al. The value of antimicrobial peptides in the age of resistance. Lancet Infect. Dis. 20, e216\u2013e230 (2020).","journal-title":"Lancet Infect. Dis."},{"key":"21526_CR14","doi-asserted-by":"publisher","first-page":"545","DOI":"10.3390\/ijms23010545","volume":"23","author":"T Vanzolini","year":"2022","unstructured":"Vanzolini, T., Bruschi, M., Rinaldi, A. C., Magnani, M. & Fraternale, A. Multitalented synthetic antimicrobial peptides and their antibacterial, antifungal and antiviral mechanisms. Int. J. Mol. Sci. 23, 545 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"21526_CR15","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.addr.2020.12.016","volume":"170","author":"Y Jiang","year":"2021","unstructured":"Jiang, Y., Chen, Y., Song, Z., Tan, Z. & Cheng, J. Recent advances in design of antimicrobial peptides and polypeptides toward clinical translation. Adv. Drug Deliv. Rev. 170, 261\u2013280 (2021).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"21526_CR16","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1080\/1040841X.2019.1599813","volume":"45","author":"Y Liu","year":"2019","unstructured":"Liu, Y., Li, R., Xiao, X. & Wang, Z. Antibiotic adjuvants: an alternative approach to overcome multi-drug resistant Gram-negative bacteria. Crit. Rev. Microbiol. 45, 301\u2013314 (2019).","journal-title":"Crit. Rev. Microbiol."},{"key":"21526_CR17","first-page":"862","volume":"24","author":"GD Wright","year":"2016","unstructured":"Wright, G. D. Antibiotic adjuvants: rescuing antibiotics from resistance. Trends Immunol. 24, 862\u2013871 (2016).","journal-title":"Trends Immunol."},{"key":"21526_CR18","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.mib.2016.05.005","volume":"33","author":"TP Zabawa","year":"2016","unstructured":"Zabawa, T. P., Pucci, M. J., Parr, T. R. & Lister, T. Treatment of Gram-negative bacterial infections by potentiation of antibiotics. Curr. Opin. Microbiol. 33, 7\u201312 (2016).","journal-title":"Curr. Opin. Microbiol."},{"key":"21526_CR19","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1021\/acs.accounts.0c00895","volume":"54","author":"KA Mu\u00f1oz","year":"2021","unstructured":"Mu\u00f1oz, K. A. & Hergenrother, P. J. Facilitating compound entry as a means to discover antibiotics for gram-negative bacteria. Acc. Chem. Res. 54, 1322\u20131333 (2021).","journal-title":"Acc. Chem. Res."},{"key":"21526_CR20","doi-asserted-by":"publisher","first-page":"5844","DOI":"10.3390\/ijms20235844","volume":"20","author":"G Annunziato","year":"2019","unstructured":"Annunziato, G. Strategies to overcome antimicrobial resistance (AMR) making use of non-essential target inhibitors: a review. Int. J. Mol. Sci. 20, 5844 (2019).","journal-title":"Int. J. Mol. Sci."},{"key":"21526_CR21","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1038\/nbt1309","volume":"25","author":"IS Radzishevsky","year":"2007","unstructured":"Radzishevsky, I. S. et al. Improved antimicrobial peptides based on acyl-lysine oligomers. Nat. Biotechnol. 25, 657\u2013659 (2007).","journal-title":"Nat. Biotechnol."},{"key":"21526_CR22","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1093\/infdis\/jix119","volume":"215","author":"J Jammal","year":"2017","unstructured":"Jammal, J., Zaknoon, F., Kaneti, G., Hershkovits, A. S. & Mor, A. Sensitization of gram-negative bacilli to host antibacterial proteins. J. Infect. Dis. 215, 1599\u20131607 (2017).","journal-title":"J. Infect. Dis."},{"key":"21526_CR23","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.3390\/pharmaceutics13111947","volume":"13","author":"F Zaknoon","year":"2021","unstructured":"Zaknoon, F., Meir, O. & Mor, A. Mechanistic studies of antibiotic adjuvants reducing kidney\u2019s bacterial loads upon systemic monotherapy. Pharmaceutics 13, 1947 (2021).","journal-title":"Pharmaceutics"},{"key":"21526_CR24","doi-asserted-by":"publisher","first-page":"2198","DOI":"10.1038\/s41598-017-02373-0","volume":"7","author":"O Meir","year":"2017","unstructured":"Meir, O., Zaknoon, F., Cogan, U. & Mor, A. A broad-spectrum bactericidal lipopeptide with anti-biofilm properties. Sci. Rep. 7, 2198 (2017).","journal-title":"Sci. Rep."},{"key":"21526_CR25","doi-asserted-by":"publisher","first-page":"2267","DOI":"10.1007\/s00018-011-0718-2","volume":"68","author":"ML Mangoni","year":"2011","unstructured":"Mangoni, M. L. & Shai, Y. Short native antimicrobial peptides and engineered ultrashort lipopeptides: similarities and differences in cell specificities and modes of action. Cell. Mol. Life Sci. 68, 2267\u20132280 (2011).","journal-title":"Cell. Mol. Life Sci."},{"key":"21526_CR26","doi-asserted-by":"crossref","unstructured":"Jammal, J., Zaknoon, F., Kaneti, G., Goldberg, K. & Mor, A. Sensitization of Gram-negative bacteria to rifampin and OAK combinations. Sci. Rep. 5, (2015).","DOI":"10.1038\/srep09216"},{"key":"21526_CR27","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1002\/cbic.201000073","volume":"11","author":"Y Lan","year":"2010","unstructured":"Lan, Y. et al. Incorporation of 2,3-diaminopropionic acid into linear cationic amphipathic peptides produces pH-sensitive vectors. ChemBioChem 11, 1266\u20131272 (2010).","journal-title":"ChemBioChem"},{"key":"21526_CR28","unstructured":"Properties of Amino Acids. In CRC Handbook of Chemistry and Physics (ed. Rumble, J. R.) (CRC Press\/Taylor & Francis, 2021)."},{"key":"21526_CR29","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1096\/fj.201700652r","volume":"32","author":"J Jammal","year":"2018","unstructured":"Jammal, J., Zaknoon, F. & Mor, A. Eliciting improved antibacterial efficacy of host proteins in the presence of antibiotics. FASEB J. 32, 369\u2013376 (2018).","journal-title":"FASEB J."},{"key":"21526_CR30","doi-asserted-by":"publisher","first-page":"00200","DOI":"10.1128\/AAC.00200-17","volume":"61","author":"D Corbett","year":"2017","unstructured":"Corbett, D. et al. Potentiation of antibiotic activity by a novel cationic peptide: potency and spectrum of activity of SPR741. Antimicrob. Agents Chemother. 61, 00200\u201300217 (2017).","journal-title":"Antimicrob. Agents Chemother."},{"key":"21526_CR31","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1128\/AAC.24.1.107","volume":"24","author":"M Vaara","year":"1983","unstructured":"Vaara, M. & Vaara, T. Polycations sensitize enteric bacteria to antibiotics. Antimicrob. Agents Chemother. 24, 107\u2013113 (1983).","journal-title":"Antimicrob. Agents Chemother."},{"key":"21526_CR32","unstructured":"Spero Therapeutics, I. Form 10-K: SEC Annual Report. (2020)."},{"key":"21526_CR33","unstructured":"Clinical and Laboratory Standards Institute. M100: Performance Standards for Antimicrobial Susceptibility Testing (2022)."},{"key":"21526_CR34","doi-asserted-by":"publisher","unstructured":"Centers for Disease Control, U. S. Antibiotic resistance threats in the United States, 2019. (2019). doi:https:\/\/doi.org\/10.15620\/cdc:82532","DOI":"10.15620\/cdc:82532"},{"key":"21526_CR35","unstructured":"Part VIII: Chemotherapuetic drugs. In Katzung & Trevor\u2019s Pharmacology: Examination & Board Review (eds. Katzung, B. G., Kruidering-Hall, M., Tuan, R. L., Vanderah, T. W. & Trevor, A. J.) (McGraw Hill Education, 2021)."},{"key":"21526_CR36","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1086\/324626","volume":"34","author":"R Leclercq","year":"2002","unstructured":"Leclercq, R. Mechanisms of resistance to macrolides and lincosamides: nature of the resistance elements and their clinical implications. Clin. Infect. Dis. 34, 482\u2013492 (2002).","journal-title":"Clin. Infect. Dis."},{"key":"21526_CR37","doi-asserted-by":"publisher","first-page":"2590","DOI":"10.1128\/AAC.42.10.2590","volume":"42","author":"N Aubry-damon","year":"1998","unstructured":"Aubry-damon, N., Soussy, C. & Courvalin, P. Characterization of mutations in the rpoB gene that confer Rifampin resistance in Staphylococcus aureus. Antimicrob. Agents Chemother. 42, 2590\u20132594 (1998).","journal-title":"Antimicrob. Agents Chemother."},{"key":"21526_CR38","doi-asserted-by":"publisher","first-page":"016515","DOI":"10.1128\/mBio.01615-20","volume":"11","author":"CR Macnair","year":"2020","unstructured":"Macnair, C. R. & Brown, E. D. Outer membrane disruption overcomes intrinsic, acquired, and spontaneous antibiotic resistance. MBio 11, 016515\u2013016520 (2020).","journal-title":"MBio"},{"key":"21526_CR39","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1038\/nrmicro2133","volume":"7","author":"PJ Yeh","year":"2009","unstructured":"Yeh, P. J., Hegreness, M. J., Aiden, A. P. & Kishony, R. Drug interactions and the evolution of antibiotic resistance. Nat. Rev. Microbiol. 7, 460\u2013466 (2009).","journal-title":"Nat. Rev. Microbiol."},{"key":"21526_CR40","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.chembiol.2018.01.005","volume":"25","author":"T Velkov","year":"2018","unstructured":"Velkov, T. et al. Structure, function, and biosynthetic origin of octapeptin antibiotics active against extensively drug-resistant gram-negative bacteria. Cell Chem. Biol. 25, 380-391.e5 (2018).","journal-title":"Cell Chem. Biol."},{"key":"21526_CR41","doi-asserted-by":"publisher","first-page":"3452","DOI":"10.1038\/s41598-019-39659-4","volume":"9","author":"R Ferrer-Espada","year":"2019","unstructured":"Ferrer-Espada, R. et al. A permeability-increasing drug synergizes with bacterial efflux pump inhibitors and restores susceptibility to antibiotics in multi-drug resistant Pseudomonas aeruginosa strains. Sci. Rep. 9, 3452 (2019).","journal-title":"Sci. Rep."},{"key":"21526_CR42","doi-asserted-by":"publisher","first-page":"11498","DOI":"10.1074\/jbc.M806587200","volume":"284","author":"J Mares","year":"2009","unstructured":"Mares, J., Kumaran, S., Gobbo, M. & Zerbe, O. Interactions of lipopolysaccharide and polymyxin studied by NMR spectroscopy. J. Biol. Chem. 284, 11498\u201311506 (2009).","journal-title":"J. Biol. Chem."},{"key":"21526_CR43","doi-asserted-by":"publisher","first-page":"18547","DOI":"10.1371\/journal.pone.0018547","volume":"6","author":"Y Matsumoto","year":"2011","unstructured":"Matsumoto, Y. et al. Evaluation of multidrug efflux pump inhibitors by a new method using microfluidic channels. PLoS ONE 6, 18547 (2011).","journal-title":"PLoS ONE"},{"key":"21526_CR44","doi-asserted-by":"crossref","unstructured":"Sundaramoorthy, N. S., Suresh, P., Selva Ganesan, S., Ganeshprasad, A. & Nagarajan, S. Restoring colistin sensitivity in colistin-resistant E. coli: combinatorial use of MarR inhibitor with efflux pump inhibitor. Sci. Rep. 9, 19845 (2019).","DOI":"10.1038\/s41598-019-56325-x"},{"key":"21526_CR45","doi-asserted-by":"crossref","unstructured":"Warner, D. M., Levy, S. B. & Stuart Levy, C. B. Different effects of transcriptional regulators MarA, SoxS and Rob on susceptibility of Escherichia coli to cationic antimicrobial peptides (CAMPs): Rob-dependent CAMP induction of the marRAB operon. Microbiology 156, 570\u2013578 (2010).","DOI":"10.1099\/mic.0.033415-0"},{"key":"21526_CR46","doi-asserted-by":"publisher","first-page":"3818","DOI":"10.1096\/fj.13-227942","volume":"27","author":"K Goldberg","year":"2013","unstructured":"Goldberg, K. et al. Sensitization of gram-negative bacteria by targeting the membrane potential. FASEB J. 27, 3818\u20133826 (2013).","journal-title":"FASEB J."},{"key":"21526_CR47","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1021\/acsinfecdis.9b00159","volume":"6","author":"S French","year":"2019","unstructured":"French, S. et al. Potentiation of antibiotics against gram-negative bacteria by polymyxin B analogue SPR741 from unique perturbation of the outer membrane. ACS Infect. Dis. 6, 1405\u20131412 (2019).","journal-title":"ACS Infect. Dis."},{"key":"21526_CR48","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1128\/JB.186.6.1851-1860.2004","volume":"186","author":"AM Augustus","year":"2004","unstructured":"Augustus, A. M., Celaya, T., Husain, F., Humbard, M. & Misra, R. Antibiotic-sensitive TolC mutants and their suppressors. J. Bacteriol. 186, 1851\u20131860 (2004).","journal-title":"J. Bacteriol."},{"key":"21526_CR49","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1128\/CMR.00117-14","volume":"28","author":"XZ Li","year":"2015","unstructured":"Li, X. Z., Pl\u00e9siat, P. & Nikaido, H. The challenge of efflux-mediated antibiotic resistance in Gram-negative bacteria. Clin. Microbiol. Rev. 28, 337\u2013418 (2015).","journal-title":"Clin. Microbiol. Rev."},{"key":"21526_CR50","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1128\/AAC.45.1.105-116.2001","volume":"45","author":"O Lomovskaya","year":"2001","unstructured":"Lomovskaya, O. et al. Identification and characterization of inhibitors of multidrug resistance efflux pumps in Pseudomonas aeruginosa: novel agents for combination therapy. Antimicrob. Agents Chemother. 45, 105\u2013116 (2001).","journal-title":"Antimicrob. Agents Chemother."},{"key":"21526_CR51","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1128\/AAC.49.2.849-852.2005","volume":"49","author":"JA Bohnert","year":"2005","unstructured":"Bohnert, J. A. & Kern, W. V. Selected arylpiperazines are capable of reversing multidrug resistance in Escherichia coli overexpressing RND efflux pumps. Antimicrob. Agents Chemother. 49, 849\u2013852 (2005).","journal-title":"Antimicrob. Agents Chemother."},{"key":"21526_CR52","doi-asserted-by":"publisher","first-page":"470","DOI":"10.3390\/molecules24030470","volume":"24","author":"S Schuster","year":"2019","unstructured":"Schuster, S., Bohnert, J. A., Vavra, M., Rossen, J. W. & Kern, W. V. Proof of an outer membrane target of the efflux inhibitor phe-arg-\u03b2-naphthylamide from random mutagenesis. Molecules 24, 470 (2019).","journal-title":"Molecules"},{"key":"21526_CR53","doi-asserted-by":"publisher","first-page":"92","DOI":"10.3389\/fmicb.2019.00092","volume":"10","author":"J Anes","year":"2019","unstructured":"Anes, J., Sivasankaran, S. K., Muthappa, D. M., Fanning, S. & Srikumar, S. Exposure to sub-inhibitory concentrations of the chemosensitizer 1-(1-naphthylmethyl)-piperazine creates membrane destabilization in multi-drug resistant Klebsiella pneumoniae. Front. Microbiol. 10, 92 (2019).","journal-title":"Front. Microbiol."},{"key":"21526_CR54","doi-asserted-by":"publisher","first-page":"5854","DOI":"10.1073\/pnas.0901695106","volume":"106","author":"K Nagano","year":"2009","unstructured":"Nagano, K. & Nikaido, H. Kinetic behavior of the major multidrug efflux pump AcrB of Escherichia coli. Proc. Natl. Acad. Sci. USA. 106, 5854\u20135858 (2009).","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"21526_CR55","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/0006-291X(62)90189-4","volume":"7","author":"PG Heytler","year":"1962","unstructured":"Heytler, P. G. & Prichard, W. W. A new class of uncoupling agents: carbonyl cyanide phenylhydrazones. Biochem. Biophys. Res. Commun. 7, 272\u2013275 (1962).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"21526_CR56","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1146\/annurev.mi.38.100184.001321","volume":"38","author":"REW Hancock","year":"1984","unstructured":"Hancock, R. E. W. Alterations in outer membrane permeability. Annu. Rev. Microbiol. 38, 237\u2013264 (1984).","journal-title":"Annu. Rev. Microbiol."},{"key":"21526_CR57","doi-asserted-by":"crossref","unstructured":"Seeger, M. A. et al. Structural asymmetry of AcrB trimer suggests a peristaltic pump mechanism. Science (80-. ). 313, 1295\u20131298 (2006).","DOI":"10.1126\/science.1131542"},{"key":"21526_CR58","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1038\/nature05076","volume":"443","author":"S Murakami","year":"2006","unstructured":"Murakami, S., Nakashima, R., Yamashita, E., Matsumoto, T. & Yamaguchi, A. Crystal structures of a multidrug transporter reveal a functionally rotating mechanism. Nature 443, 173\u2013179 (2006).","journal-title":"Nature"},{"key":"21526_CR59","doi-asserted-by":"publisher","first-page":"3509","DOI":"10.1073\/pnas.1602472113","volume":"113","author":"H Sjuts","year":"2016","unstructured":"Sjuts, H. et al. Molecular basis for inhibition of AcrB multidrug efflux pump by novel and powerful pyranopyridine derivatives. Proc. Natl. Acad. Sci. USA. 113, 3509\u20133514 (2016).","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"21526_CR60","first-page":"73","volume":"11","author":"H Vaudry","year":"2017","unstructured":"Vaudry, H. et al. Membrane active antimicrobial peptides: translating mechanistic insights to design. Front. Neurosci. 11, 73 (2017).","journal-title":"Front. Neurosci."},{"key":"21526_CR61","doi-asserted-by":"publisher","first-page":"204","DOI":"10.3389\/fchem.2018.00204","volume":"6","author":"A Hollmann","year":"2018","unstructured":"Hollmann, A., Martinez, M., Maturana, P., Semorile, L. C. & Maffia, P. C. Antimicrobial peptides: interaction with model and biological membranes and synergism with chemical antibiotics. Front. Chem. 6, 204 (2018).","journal-title":"Front. Chem."},{"key":"21526_CR62","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1016\/j.bbamem.2015.10.022","volume":"1858","author":"G Kaneti","year":"2016","unstructured":"Kaneti, G., Meir, O. & Mor, A. Controlling bacterial infections by inhibiting proton-dependent processes. Biochim. Biophys. Acta - Biomembr. 1858, 995\u20131003 (2016).","journal-title":"Biochim. Biophys. Acta - Biomembr."},{"key":"21526_CR63","doi-asserted-by":"crossref","unstructured":"Merrifield, R. B. Solid phase peptide synthesis. I. The synthesis of a tetrapeptide1. J. Am. Chem. Soc. 85, 2149\u20132154 (1963).","DOI":"10.1021\/ja00897a025"},{"key":"21526_CR64","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1111\/j.1399-3011.1990.tb00939.x","volume":"35","author":"GB Fields","year":"1990","unstructured":"Fields, G. B. & Noble, R. L. Solid phase peptide synthesis utilizing 9-fluorenylmethoxycarbonyl amino acids. Int. J. Pept. Protein Res. 35, 161\u2013214 (1990).","journal-title":"Int. J. Pept. Protein Res."},{"key":"21526_CR65","doi-asserted-by":"publisher","first-page":"4308","DOI":"10.1128\/AAC.00656-08","volume":"52","author":"H Sarig","year":"2008","unstructured":"Sarig, H., Rotem, S., Ziserman, L., Danino, D. & Mor, A. Impact of self-assembly properties on antibacterial activity of short acyl-lysine oligomers. Antimicrob. Agents Chemother. 52, 4308\u20134314 (2008).","journal-title":"Antimicrob. Agents Chemother."},{"key":"21526_CR66","doi-asserted-by":"publisher","first-page":"1904","DOI":"10.1096\/fj.09-149427","volume":"24","author":"H Sarig","year":"2010","unstructured":"Sarig, H. et al. A miniature mimic of host defense peptides with systemic antibacterial efficacy. FASEB J. 24, 1904\u20131913 (2010).","journal-title":"FASEB J."},{"key":"21526_CR67","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1128\/AAC.26.4.546","volume":"26","author":"B Loh","year":"1984","unstructured":"Loh, B., Grant, C. & Hancock, R. E. W. Use of the fluorescent probe 1-N-phenylnaphthylamine to study the interactions of aminoglycoside antibiotics with the outer membrane of Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 26, 546\u2013551 (1984).","journal-title":"Antimicrob. Agents Chemother."},{"key":"21526_CR68","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1128\/AAC.29.3.496","volume":"29","author":"RA Moore","year":"1986","unstructured":"Moore, R. A., Bates, N. C. & Hancock, R. E. W. Interaction of polycationic antibiotics with Pseudomonas aeruginosa Lipopolysaccharide and lipid A studied by using dansyl-polymyxin. Antimicrob. Agents Chemother. 29, 496\u2013500 (1986).","journal-title":"Antimicrob. Agents Chemother."},{"key":"21526_CR69","doi-asserted-by":"publisher","first-page":"3315","DOI":"10.1021\/bi00713a022","volume":"13","author":"P Jay Sims","year":"1974","unstructured":"Jay Sims, P., Waggoner, A. S., Wang, C.-H. & Hoffman, J. F. Studies on the mechanism by which cyanine dyes measure membrane potential in red blood cells and phosphatidylcholine vesicles. Biochemistry 13, 3315\u20133330 (1974).","journal-title":"Biochemistry"},{"key":"21526_CR70","doi-asserted-by":"publisher","unstructured":"National Research Council (US) - Committee for the Update of the Guide for the Care and Use of Laboratory Animals. Guide for the Care and Use of Laboratory Animals. (2011). doi:https:\/\/doi.org\/10.17226\/12910","DOI":"10.17226\/12910"},{"key":"21526_CR71","doi-asserted-by":"publisher","unstructured":"Frimodt-M\u00f8ller, N., Knudsen, J. D. & Espersen, F. The mouse peritonitis\/sepsis model. In Handbook of Animal Models of Infection 127\u2013136 (Elsevier, 1999). doi:https:\/\/doi.org\/10.1016\/B978-012775390-4\/50153-6","DOI":"10.1016\/B978-012775390-4\/50153-6"},{"key":"21526_CR72","doi-asserted-by":"publisher","unstructured":"Hopkins, W. J. Mouse model of ascending urinary tract infection. In Handbook of Animal Models of Infection 435\u2013439 (Elsevier, 1999). doi:https:\/\/doi.org\/10.1016\/b978-012775390-4\/50189-5","DOI":"10.1016\/b978-012775390-4\/50189-5"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-21526-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-21526-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-21526-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,22]],"date-time":"2022-10-22T15:15:26Z","timestamp":1666451726000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-21526-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,21]]},"references-count":72,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["21526"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-21526-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"type":"electronic","value":"2045-2322"}],"subject":[],"published":{"date-parts":[[2022,10,21]]},"assertion":[{"value":"7 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"17673"}}